The firm is proud to introduce a new virtual series entitled, the Life Sciences Executive Exchange. This series is designed for experienced pharma professionals and executives. In each 30-minute session, we will dive into a specific phase of the pharma product lifecycle, provide attendees with the latest pharma updates and cover trends happening within the FDA and the industry in general.
In our first session, “Navigating the FDA: Bringing New Therapies to Market,” Edward John Allera, shareholder and co-chair of the firm's FDA group and Barbara Binzak Blumenfeld, shareholder in the firm's Life Sciences Industry Group will discuss the following topics:
Business solutions for your company to overcome regulatory hurdles
Finding the right path within FDA
Developing your story and honing in on clinical benefit
Recruiting patients for clinical trials in the new environment
If you missed session one, you can view the conversation here.